FDS Stock Barely Moves After Posting Q2 Earnings Beat, Revenue Rise

25.03.25 17:56 Uhr

Werte in diesem Artikel
Aktien

71,50 EUR -3,00 EUR -4,03%

32,00 JPY -1,00 JPY -3,03%

FactSet FDS has reported the results for the second quarter of fiscal 2025, with earnings surpassing the Zacks Consensus Estimate but revenues meeting the same.See Zacks Earnings Calendar to stay ahead of market-making news.The stock price has not witnessed any significant impact of the earnings beat since the company released results on March 20.FDS’s earnings per share (excluding 52 cents from non-recurring items) of $4.28 beat the consensus mark by 2.2% and increased 1.4% from the year-ago quarter. Revenues of $570.7 met the Zacks Consensus Estimate but gained 4.5% from the year-ago quarter.The company’s shares have lost 5.2% in the past six months compared with the 7.1% fall of the industry it belongs to and the 1.1% decline of the Zacks S&P 500 composite.FactSet Research Systems Inc. Price, Consensus and EPS Surprise  FactSet Research Systems Inc. price-consensus-eps-surprise-chart | FactSet Research Systems Inc. QuoteFactSet’s Revenues in DetailOrganic revenues increased 4% year over year to $568 million. Region-wise, organic revenue growth was 4% for the Americas, 3.1% for the EMEA, and 6.8% for the Asia Pacific.Revenues generated from the Americas segment were $369.7 million, up 4.8% from the year-ago quarter, surpassing our expectation of $367.6 million. Revenues from the EMEA were $143.4 million, an increase of 3% from the year-ago quarter. The figure missed our projection of $145 million. Revenues from the Asia Pacific were $57.6 million, marking 6.5% growth on a year-over-year basis, outpacing our estimate by a slight margin.FDS’s ASV Plus Professional ServicesFactSet’s Annual Subscription Value (“ASV”) plus professional services were $2.3 billion. Organic ASV plus professional services were $2.3 billion, up 4.1% from the year-ago quarter. The buy-side organic ASV growth rate was 4.1% and the sell-side organic ASV growth rate was 2.2%. Nearly 82% of organic ASV was generated by the buy-side and the rest by sell-side firms.Organic ASV generated from the United States was $1.5 billion, increasing 4.4% from the year-ago quarter. Organic ASV from the EMEA was $571.4 million, gaining 2.6% year over year. Organic ASV from the Asia Pacific was $229.9 million, up 6.8% on a year-over-year basis.FactSet added 396 clients in the second quarter of fiscal 2025, driven by corporates, including clients from the Irwin buyout, taking the total to 8,645. The annual client retention rate was 91%.FactSet’s Operating ResultsThe adjusted operating income was $212.7 million, which increased 1.6% from the year-ago quarter and beat our estimate of $210.3 million. The adjusted operating margin of 37.3% gained 100 basis points from the year-ago quarter.FDS’ Balance Sheet & Cash FlowThe company exited the quarter with a cash and cash-equivalent balance of $278.5 million compared with $289.2 million in the first quarter of fiscal 2025. The long-term debt was $1.5 billion compared with $1.3 billion in the preceding quarter.FDS generated $174 million in cash from operating activities. However, its capital expenditure was $23.7 million. The free cash flow utilized was $150.2 million.FY25 Guidance for FactSetFor fiscal 2025, the company updated its revenue expectation to $2.305-$2.325 billion from the preceding quarter’s view of $2.285-$2.305 billion. The mid-point of the guided range ($2.315 billion) is slightly higher than the Zacks Consensus Estimate of $2.31 billion.FDS anticipates earnings per share of $16.8-$17.4. The guided range's mid-point ($17.1) is in line with the consensus estimate. The adjusted operating margin is projected to be 36-37%.FactSet carries a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Earnings SnapshotAccenture plc ACN posted mixed second-quarter fiscal 2025 results.ACN’s earnings were $2.82 per share, missing the Zacks Consensus Estimate by a slight margin. The metric increased 1.8% from the year-ago quarter. Total revenues of $16.7 billion beat the consensus estimate by a slight margin but gained 5.4% on a year-over-year basis.S&P Global Inc. SPGI reported impressive fourth-quarter 2024 results.SPGI’s adjusted earnings per share (EPS) of $3.77 surpassed the Zacks Consensus Estimate by 9.6% and gained 20.4% year over year. Revenues of $3.6 billion beat the consensus estimate by 2.9% and grew 15.1% year over year.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Accenture PLC (ACN): Free Stock Analysis Report FactSet Research Systems Inc. (FDS): Free Stock Analysis Report S&P Global Inc. (SPGI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Q2

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q2

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Q2 Holdings Inc

Wer­bung

Analysen zu Q2 Holdings Inc

DatumRatingAnalyst
13.08.2019Q2 BuyCompass Point
01.03.2019Q2 BuyNeedham & Company, LLC
19.12.2018Q2 BuyBTIG Research
09.08.2018Q2 BuyNeedham & Company, LLC
11.05.2018Q2 NeutralBTIG Research
DatumRatingAnalyst
13.08.2019Q2 BuyCompass Point
01.03.2019Q2 BuyNeedham & Company, LLC
19.12.2018Q2 BuyBTIG Research
09.08.2018Q2 BuyNeedham & Company, LLC
16.02.2018Q2 BuyNeedham & Company, LLC
DatumRatingAnalyst
11.05.2018Q2 NeutralBTIG Research
18.11.2016Q2 Sector WeightPacific Crest Securities Inc.
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Q2 Holdings Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen